TY  - GEN
AU  - Ohmachi,Ken
AU  - Maruyama,Dai
AU  - Nisikori,Momoko
AU  - Suzuki,Tatsuya
AU  - Izutsu,Koji
TI  - [Recommendation for the optimal use of bendamustine in Japan]
SN  - 0485-1439
PY  - 2014///0618
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bendamustine Hydrochloride
KW  - Clinical Trials as Topic
KW  - Cytomegalovirus Infections
KW  - complications
KW  - Drug Administration Schedule
KW  - Drug Eruptions
KW  - etiology
KW  - Evidence-Based Medicine
KW  - Hepatitis B
KW  - Humans
KW  - Immunocompromised Host
KW  - Japan
KW  - Lymphoma, B-Cell
KW  - blood
KW  - Lymphoma, Mantle-Cell
KW  - Nausea
KW  - chemically induced
KW  - Nitrogen Mustard Compounds
KW  - Opportunistic Infections
KW  - Rituximab
KW  - Vasculitis
N1  - Publication Type: Journal Article; Review
ER  -